Intrahepatic Transcriptional Signature Associated with Response to Interferon-α Treatment in the Woodchuck Model of Chronic Hepatitis B

• Simon P. Fletcher,

  Current address: Gilead Sciences, Foster City, California, United States of America

  Affiliation Pharma Research & Early Development, Hoffmann-La Roche, Inc., Nutley, New Jersey, United States of America

  ⨯
• Daniel J. Chin,

  Current address: Quanticel Pharmaceuticals, San Francisco, California, United States of America

  Affiliation Pharma Research & Early Development, Hoffmann-La Roche, Inc., Nutley, New Jersey, United States of America

  ⨯
• Lore Gruenbaum,

  Current address: Roche Pharma Research & Early Development, Roche Innovation Center New York, New York, New York, United States of America

  Affiliation Pharma Research & Early Development, Hoffmann-La Roche, Inc., Nutley, New Jersey, United States of America

  ⨯
• Hans Bitter,

  Current address: Novartis Institutes for Biomedical Research, Cambridge, Massachusetts, United States of America

  Affiliation Pharma Research & Early Development, Hoffmann-La Roche, Inc., Nutley, New Jersey, United States of America

  ⨯
• Erik Rasmussen,

  Current address: Regeneron Pharmaceuticals, Tarrytown, New York, United States of America

  Affiliation Pharma Research & Early Development, Hoffmann-La Roche, Inc., Nutley, New Jersey, United States of America

  ⨯
• Palanikumar Ravindran,

  Current address: Bristol-Myers Squibb Company, Princeton, New Jersey, United States of America

  Affiliation Pharma Research & Early Development, Hoffmann-La Roche, Inc., Nutley, New Jersey, United States of America

  ⨯
• David C. Swinney,

  Current address: iRND3, Institute for Rare and Neglected Diseases Drug Discovery, Mountain View, California, United States of America

  Affiliation Pharma Research & Early Development, Hoffmann-La Roche, Inc., Nutley, New Jersey, United States of America

  ⨯
• Fabian Birzele,

  Affiliation Roche Pharma Research & Early Development, Roche Innovation Center Penzberg, Penzberg, Germany

  ⨯
• Roland Schmucki,

  Affiliation Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland

  ⨯
• Stefan H. Lorenz,

  Affiliation Roche Pharma Research & Early Development, Roche Innovation Center Penzberg, Penzberg, Germany

  ⨯
• Erhard Kopetzki,

  Affiliation Roche Pharma Research & Early Development, Roche Innovation Center Penzberg, Penzberg, Germany

  ⨯
• Jade Carter,

  Current address: New York Genome Center, New York, New York, United States of America

  Affiliation Pharma Research & Early Development, Hoffmann-La Roche, Inc., Nutley, New Jersey, United States of America

  ⨯
• Miriam Triyatni,

  Affiliation Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland

  ⨯
• Linta M. Thampi,

  Affiliation Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, District of Columbia, United States of America

  ⨯
• Junming Yang,

  Affiliation Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, District of Columbia, United States of America

  ⨯
• Dalal AlDeghaither,

  Affiliation Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, District of Columbia, United States of America

  ⨯
• Marta G. Murredu,

  Affiliation Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, District of Columbia, United States of America

  ⨯
• Paul Cote,

  Affiliation Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, District of Columbia, United States of America

  ⨯
•  [ ... ],
• Stephan Menne

  * E-mail: sm923@georgetown.edu

  Affiliation Department of Microbiology & Immunology, Georgetown University Medical Center, Washington, District of Columbia, United States of America

  ⨯
• [ view all ]
• [ view less ]